Evidence map›Paper›PMID 41794979›Full record

ArticleScientific reports2026

Fractional spatiotemporal Hahnfeldt tumor model with convergence analysis and optimal control.

Engin Can

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Engin CanDepartment of Fundamental Sciences of Engineering, Faculty of Technology, Sakarya University of Applied Sciences, Sakarya, Turkey. ecan@subu.edu.tr.ORCID http://orcid.org/0000-0002-4105-6460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mathematical modeling of tumor-immune interactions is pivotal for decoding the complex, multistage processes of cancer progression, yet classical integer-order models often fail to capture the hereditary properties and spatial heterogeneity intrinsic to malignant growth. This research presents a novel fractional spatiotemporal Hahnfeldt tumor model that integrates Caputo fractional derivatives with diffusion mechanisms to characterize memory dependent tumor vascular dynamics. Unlike standard formulations, this model explicitly accounts for the "biological memory" of the immune system and the "sub-diffusive" invasion patterns of tumor cells. We provide a rigorous mathematical analysis, establishing the non-negativity and boundedness of solutions, followed by a stability analysis of the Adams-Bashforth-Moulton predictor-corrector scheme. Numerical simulations reveal that lower fractional order inherently reproduce clinical phenomena such as tumor dormancy and delayed therapeutic response, which are mathematically inaccessible to integer-order counterparts. Furthermore, a fractional optimal control framework, solved via the Forward-Backward Sweep Method, demonstrates that adaptive chemo-immunotherapy significantly outperforms monotherapies by leveraging the system's memory to sustain remission. These findings offer a theoretically sound and clinically relevant computational tool for predicting long-term treatment outcomes in heterogeneous tissue environments.

Indexed as

Models, BiologicalModels, TheoreticalNeoplasmsComputer SimulationHumansImmunotherapyChemo-immunotherapyFractional calculusHahnfeldt modelOptimal controlSpatio-temporal modelingTumor-immune dynamics

Identifiers

PMID41794979
PMCPMC13087137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.